National Drug and Alcohol Research Centre, University of New South Wales, NSW, Australia.
Justice Health and Forensic Mental Health Network, NSW Health, NSW, Australia.
Addiction. 2017 Dec;112(12):2191-2201. doi: 10.1111/add.13897. Epub 2017 Jul 11.
To (1) assess trends in the number and mortality rates of methamphetamine-related death in Australia, 2009-15; (2) assess the characteristics and the cause, manner and circumstances of death; and (3) assess the blood methamphetamine concentrations and the presence of other drugs in methamphetamine-related death.
Analysis of cases of methamphetamine-related death retrieved from the National Coronial Information System (NCIS).
Australia.
All cases in which methamphetamine was coded in the NCIS database as a mechanism contributing to death (n = 1649).
Information was collected on cause and manner of death, demographics, location, circumstances of death and toxicology.
The mean age of cases was 36.9 years, and 78.4% were male. The crude mortality rate was 1.03 per 100 000. The rate increased significantly over time (P < 0.001), and at 2015 the mortality rate was 1.8 [confidence interval (CI) = 1.2-2.4] times that of 2009. Deaths were due to accidental drug toxicity (43.2%), natural disease (22.3%), suicide (18.2%), other accident (14.9%) and homicide (1.5%). In 40.8% of cases, death occurred outside the major capital cities. The median blood methamphetamine concentration was 0.17 mg/l, and cases in which only methamphetamine was detected had higher concentrations than other cases (0.30 versus 0.15 mg/l, P < 0.001). The median blood methamphetamine concentration varied within a narrow range (0.15-0.20 mg/l) across manner of death. In the majority (82.8%) of cases, substances other than methamphetamine were detected, most frequently opioids (43.1%) and hypnosedatives (38.0%).
Methamphetamine death rates doubled in Australia from 2009 to 2015. While toxicity was the most frequent cause, natural disease, suicide and accident comprised more than half of deaths.
(1)评估 2009-2015 年期间澳大利亚与甲基苯丙胺相关的死亡人数和死亡率的趋势;(2)评估特征以及死因、方式和情况;(3)评估与甲基苯丙胺相关的死亡者的血液中甲基苯丙胺浓度以及其他药物的存在情况。
对国家验尸官信息系统(NCIS)中检索到的与甲基苯丙胺相关的死亡案例进行分析。
澳大利亚。
NCIS 数据库中将甲基苯丙胺编码为导致死亡的机制的所有案例(n=1649)。
收集死因和死亡方式、人口统计学、位置、死亡情况和毒理学方面的信息。
案例的平均年龄为 36.9 岁,78.4%为男性。粗死亡率为每 10 万人 1.03 人。该比率呈显著上升趋势(P<0.001),到 2015 年,死亡率是 2009 年的 1.8 倍(置信区间[CI]为 1.2-2.4)。死亡归因于意外药物毒性(43.2%)、自然疾病(22.3%)、自杀(18.2%)、其他事故(14.9%)和他杀(1.5%)。在 40.8%的案例中,死亡发生在主要首府城市之外。血液中甲基苯丙胺的中位数浓度为 0.17mg/L,且仅检测到甲基苯丙胺的案例的浓度高于其他案例(0.30 与 0.15mg/L,P<0.001)。不同死因方式下,血液中甲基苯丙胺的中位数浓度在一个较窄的范围内(0.15-0.20mg/L)变化。在大多数案例(82.8%)中,除了甲基苯丙胺以外还检测到其他物质,最常见的是阿片类药物(43.1%)和催眠镇静剂(38.0%)。
2009 年至 2015 年期间,澳大利亚与甲基苯丙胺相关的死亡率增加了一倍。虽然毒性是最常见的原因,但自然疾病、自杀和事故导致的死亡占一半以上。